A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside

被引：14

作者：

Radi, Giulia ^{[1
]}

Campanti, Anna ^{[1
]}

Diotallevi, Federico ^{[1
]}

Martina, Emanuela ^{[1
]}

Marani, Andrea ^{[1
]}

Offidani, Annamaria ^{[1
]}

机构：

[1] Polytech Marche Univ, Dermatol Clin, Dept Clin & Mol Sci, I-60126 Ancona, Italy

来源：

BIOMEDICINES | 2022年 / 10卷 / 11期

关键词：

atopic dermatitis; pathophysiology; small molecules; biologics; novel treatments; DOUBLE-BLIND; EPIDERMAL BARRIER; BASIC SCIENCE; PLACEBO; PHASE-3; ADOLESCENTS; RECEPTORS; CYTOKINES; EFFICACY; ADULTS;

D O I：

10.3390/biomedicines10112700

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Atopic dermatitis (AD) is a common chronic inflammatory and immune-mediated skin disease with a complex pathophysiology and still represents a therapeutic challenge, owing to limited responses to available treatments. However, recent advances in the understanding of AD pathophysiology have led to the discovery of several new potential therapeutic targets, and research in the field of new molecules with therapeutic perspectives is boiling, with more than 70 new promising drugs in development. The aim of this systematic review is to provide the state of the art on the current knowledge concerning the pathophysiology of the disease and on novel agents currently being investigated for AD, and to highlight which type of evolution is going to take place in therapeutic approaches of atopic dermatitis in the coming years.

引用

页数：28

共 89 条

[71]

Silverberg NB, 2015, CUTIS, V96, P359

[72] Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials [J].

Simpson, E. L. ;

Lacour, J. -P. ;

Spelman, L. ;

Galimberti, R. ;

Eichenfield, L. F. ;

Bissonnette, R. ;

King, B. A. ;

Thyssen, J. P. ;

Silverberg, J. I. ;

Bieber, T. ;

Kabashima, K. ;

Tsunemi, Y. ;

Costanzo, A. ;

Guttman-Yassky, E. ;

Beck, L. A. ;

Janes, J. M. ;

DeLozier, A. M. ;

Gamalo, M. ;

Brinker, D. R. ;

Cardillo, T. ;

Nunes, F. P. ;

Paller, A. S. ;

Wollenberg, A. ;

Reich, K. .

BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (02) :242-255

[73]

Simpson EL, 2020, LANCET, V396, P255, DOI 10.1016/S0140-6736(20)30732-7

[74] Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial [J].

Simpson, Eric L. ;

Parnes, Jane R. ;

She, Dewei ;

Crouch, Sarah ;

Rees, William ;

Mo, May ;

van der Merwe, Rene .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) :1013-1021

[75] Importance of genetic factors in the etiology of atopic dermatitis: A twin study [J].

Thomsen, Simon F. ;

Ulrik, Charlotte S. ;

Kyvik, Kirsten O. ;

Hjelmborg, Jacob v. B. ;

Skadhauge, Lars R. ;

Steffensen, Ida ;

Backer, Vibeke .

ALLERGY AND ASTHMA PROCEEDINGS, 2007, 28 (05) :535-539

[76] The histamine H4 receptor: from orphan to the clinic [J].

Thurmond, Robin L. .

FRONTIERS IN PHARMACOLOGY, 2015, 6

[77] Adult-Onset Atopic Dermatitis: Characteristics and Management [J].

Vakharia, Paras P. ;

Silverberg, Jonathan I. .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (06) :771-779

[78] Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis [J].

van den Bogaard, Ellen H. ;

Bergboer, Judith G. M. ;

Vonk-Bergers, Mieke ;

van Vlijmen-Willems, Ivonne M. J. J. ;

Hato, Stanleyson V. ;

van der Valk, Pieter G. M. ;

Schroeder, Jens Michael ;

Joosten, Irma ;

Zeeuwen, Patrick L. J. M. ;

Schalkwijk, Joost .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (02) :917-927

[79] Mechanisms and consequences of Jak-STAT signaling in the immune system [J].

Villarino, Alejandro V. ;

Kanno, Yuka ;

O'Shea, John J. .

NATURE IMMUNOLOGY, 2017, 18 (04) :374-384

[80] Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial [J].

Weiss, Anne ;

Delavenne, Emilie ;

Matias, Carina ;

Lagler, Heimo ;

Simon, Daniel ;

Li, Ping ;

Hansen, Jon U. ;

dos Santos, Teresa Pires ;

Jana, Bimal ;

Priemel, Petra ;

Bangert, Christine ;

Bauer, Martin ;

Eberl, Sabine ;

Nussbaumer-Proell, Alina ;

Oesterreicher, Zoe Anne ;

Matzneller, Peter ;

Quint, Tamara ;

Weber, Maria ;

Nielsen, Hanne Morck ;

Rades, Thomas ;

Johansen, Helle Krogh ;

Westh, Henrik ;

Kim, Wooseong ;

Mylonakis, Eleftherios ;

Friis, Christian ;

Guardabassi, Luca ;

Pace, John ;

Lundberg, Carina Vingsbo ;

M'Zali, Fatima ;

Butty, Pascal ;

Sorensen, Nikolaj ;

Nielsen, Henrik Bjorn ;

Toft-Kehler, Rasmus ;

Guttman-Yassky, Emma ;

Stingl, Georg ;

Zeitlinger, Markus ;

Sommer, Morten .

CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (05)

← 1 2 3 4 5 6 7 8 9 →